CTNM
Contineum Therapeutics, Inc. Class A Common StockstockNASDAQ
Market OpenNov 19, 2026 3:22:58 PM EST
8.94USD-3.247%(-0.30)122,467
CTNM Financials
In Q3 FY 2026 (ended ), Contineum Therapeutics, Inc. Class A Common Stock (CTNM) reported net income of −$18.7M, operating cash flow of −$11.06M, and assets of $256.99M (filed ).
Loading financial statements…